InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Giacobello Scott M., Chief Financial Officer. Officer active across 3 companies, notably GW Pharmaceuticals PLC. In total, 7 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €748k. History available since 26 September 2022. The latest transaction was disclosed on 16 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Giacobello Scott M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
77,000 shares@ US$3.8633.6% of flowCommon StockSEC:0001754154-26-000010:0
141,600 shares@ US$4.1366.4% of flowCommon StockSEC:0001754154-26-000010:1
473,902 sharesCommon StockSEC:0001754154-26-000005:0
6,750 sharesCommon StockSEC:0001754154-26-000002:0
6,750 sharesCommon StockSEC:0001415889-25-006318:0
20,000 shares@ US$12.50100.0% of flowCommon StockSEC:0001209191-22-051388:0
165,108 sharesOrdinary SharesSEC:0000899243-21-018661:0
7 of 7 declarations
About Giacobello Scott M.
Scott M. Giacobello is the Chief Financial Officer at GW Pharmaceuticals PLC. In this role, he is responsible for financial management and strategy of the company, which specializes in drug development. Scott plays a key role in financial planning and compliance, thereby contributing to the growth of the firm.
